Cargando…

2-Heptylcyclopropane-1-Carboxylic Acid Disperses and Inhibits Bacterial Biofilms

Fatty-acid signaling molecules can inhibit biofilm formation, signal dispersal events, and revert dormant cells within biofilms to a metabolically active state. We synthesized 2-heptylcyclopropane-1-carboxylic acid (2CP), an analog of cis-2-decenoic acid (C2DA), which contains a cyclopropanated bond...

Descripción completa

Detalles Bibliográficos
Autores principales: Harrison, Zoe L., Awais, Rukhsana, Harris, Michael, Raji, Babatunde, Hoffman, Brian C., Baker, Daniel L., Jennings, Jessica Amber
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8221421/
https://www.ncbi.nlm.nih.gov/pubmed/34177826
http://dx.doi.org/10.3389/fmicb.2021.645180
_version_ 1783711323461255168
author Harrison, Zoe L.
Awais, Rukhsana
Harris, Michael
Raji, Babatunde
Hoffman, Brian C.
Baker, Daniel L.
Jennings, Jessica Amber
author_facet Harrison, Zoe L.
Awais, Rukhsana
Harris, Michael
Raji, Babatunde
Hoffman, Brian C.
Baker, Daniel L.
Jennings, Jessica Amber
author_sort Harrison, Zoe L.
collection PubMed
description Fatty-acid signaling molecules can inhibit biofilm formation, signal dispersal events, and revert dormant cells within biofilms to a metabolically active state. We synthesized 2-heptylcyclopropane-1-carboxylic acid (2CP), an analog of cis-2-decenoic acid (C2DA), which contains a cyclopropanated bond that may lock the signaling factor in an active state and prevent isomerization to its least active trans-configuration (T2DA). 2CP was compared to C2DA and T2DA for ability to disperse biofilms formed by Staphylococcus aureus and Pseudomonas aeruginosa. 2CP at 125 μg/ml dispersed approximately 100% of S. aureus cells compared to 25% for C2DA; both 2CP and C2DA had significantly less S. aureus biofilm remaining compared to T2DA, which achieved no significant dispersal. 2CP at 125 μg/ml dispersed approximately 60% of P. aeruginosa biofilms, whereas C2DA and T2DA at the same concentration dispersed 40%. When combined with antibiotics tobramycin, tetracycline, or levofloxacin, 2CP decreased the minimum concentration required for biofilm inhibition and eradication, demonstrating synergistic and additive responses for certain combinations. Furthermore, 2CP supported fibroblast viability above 80% for concentrations below 1 mg/ml. This study demonstrates that 2CP shows similar or improved efficacy in biofilm dispersion, inhibition, and eradication compared to C2DA and T2DA and thus may be promising for use in preventing infection for healthcare applications.
format Online
Article
Text
id pubmed-8221421
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-82214212021-06-24 2-Heptylcyclopropane-1-Carboxylic Acid Disperses and Inhibits Bacterial Biofilms Harrison, Zoe L. Awais, Rukhsana Harris, Michael Raji, Babatunde Hoffman, Brian C. Baker, Daniel L. Jennings, Jessica Amber Front Microbiol Microbiology Fatty-acid signaling molecules can inhibit biofilm formation, signal dispersal events, and revert dormant cells within biofilms to a metabolically active state. We synthesized 2-heptylcyclopropane-1-carboxylic acid (2CP), an analog of cis-2-decenoic acid (C2DA), which contains a cyclopropanated bond that may lock the signaling factor in an active state and prevent isomerization to its least active trans-configuration (T2DA). 2CP was compared to C2DA and T2DA for ability to disperse biofilms formed by Staphylococcus aureus and Pseudomonas aeruginosa. 2CP at 125 μg/ml dispersed approximately 100% of S. aureus cells compared to 25% for C2DA; both 2CP and C2DA had significantly less S. aureus biofilm remaining compared to T2DA, which achieved no significant dispersal. 2CP at 125 μg/ml dispersed approximately 60% of P. aeruginosa biofilms, whereas C2DA and T2DA at the same concentration dispersed 40%. When combined with antibiotics tobramycin, tetracycline, or levofloxacin, 2CP decreased the minimum concentration required for biofilm inhibition and eradication, demonstrating synergistic and additive responses for certain combinations. Furthermore, 2CP supported fibroblast viability above 80% for concentrations below 1 mg/ml. This study demonstrates that 2CP shows similar or improved efficacy in biofilm dispersion, inhibition, and eradication compared to C2DA and T2DA and thus may be promising for use in preventing infection for healthcare applications. Frontiers Media S.A. 2021-06-09 /pmc/articles/PMC8221421/ /pubmed/34177826 http://dx.doi.org/10.3389/fmicb.2021.645180 Text en Copyright © 2021 Harrison, Awais, Harris, Raji, Hoffman, Baker and Jennings. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Microbiology
Harrison, Zoe L.
Awais, Rukhsana
Harris, Michael
Raji, Babatunde
Hoffman, Brian C.
Baker, Daniel L.
Jennings, Jessica Amber
2-Heptylcyclopropane-1-Carboxylic Acid Disperses and Inhibits Bacterial Biofilms
title 2-Heptylcyclopropane-1-Carboxylic Acid Disperses and Inhibits Bacterial Biofilms
title_full 2-Heptylcyclopropane-1-Carboxylic Acid Disperses and Inhibits Bacterial Biofilms
title_fullStr 2-Heptylcyclopropane-1-Carboxylic Acid Disperses and Inhibits Bacterial Biofilms
title_full_unstemmed 2-Heptylcyclopropane-1-Carboxylic Acid Disperses and Inhibits Bacterial Biofilms
title_short 2-Heptylcyclopropane-1-Carboxylic Acid Disperses and Inhibits Bacterial Biofilms
title_sort 2-heptylcyclopropane-1-carboxylic acid disperses and inhibits bacterial biofilms
topic Microbiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8221421/
https://www.ncbi.nlm.nih.gov/pubmed/34177826
http://dx.doi.org/10.3389/fmicb.2021.645180
work_keys_str_mv AT harrisonzoel 2heptylcyclopropane1carboxylicaciddispersesandinhibitsbacterialbiofilms
AT awaisrukhsana 2heptylcyclopropane1carboxylicaciddispersesandinhibitsbacterialbiofilms
AT harrismichael 2heptylcyclopropane1carboxylicaciddispersesandinhibitsbacterialbiofilms
AT rajibabatunde 2heptylcyclopropane1carboxylicaciddispersesandinhibitsbacterialbiofilms
AT hoffmanbrianc 2heptylcyclopropane1carboxylicaciddispersesandinhibitsbacterialbiofilms
AT bakerdaniell 2heptylcyclopropane1carboxylicaciddispersesandinhibitsbacterialbiofilms
AT jenningsjessicaamber 2heptylcyclopropane1carboxylicaciddispersesandinhibitsbacterialbiofilms